Cargando…

Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19

Detalles Bibliográficos
Autor principal:	Hooper, Philip L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630687/ https://www.ncbi.nlm.nih.gov/pubmed/34846631 http://dx.doi.org/10.1007/s12192-021-01246-w

Ejemplares similares

Fluvoxamine, melatonin and COVID-19
por: Anderson, George M.
Publicado: (2021)

COVID-19 and heme oxygenase: novel insight into the disease and potential therapies
por: Hooper, Philip L.
Publicado: (2020)

Correction to: COVID-19 and heme oxygenase: novel insight into the disease and potential therapies
por: Hooper, Philip L.
Publicado: (2020)

Old drug fluvoxamine, new hope for COVID-19
por: Hashimoto, Yaeko, et al.
Publicado: (2021)

Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis
por: Cheema, Huzaifa Ahmad, et al.
Publicado: (2022)

Repurposing fluvoxamine, and other psychiatric medications, for COVID‐19 and other conditions
por: Lenze, Eric J., et al.
Publicado: (2022)

Emergence of kleptomania during treatment for obsessive compulsive disorder with fluvoxamine
por: Gupta, Parveen Rani
Publicado: (2014)

A meta-analysis regarding fluvoxamine and hospitalization risk of COVID-19 patients: TOGETHER making a difference
por: Marcec, Robert, et al.
Publicado: (2022)

There is no reasonable evidence to support efficacy of fluvoxamine in prevention of disease deterioration in COVID-19 outpatients: A comment on two recent meta-analyses advocating its use
por: Trkulja, Vladimir
Publicado: (2022)

Fluvoxamine for the treatment of COVID-19
por: Dodds, Michael G, et al.
Publicado: (2022)

Fluvoxamine for the treatment of COVID-19
por: Boulware, David R, et al.
Publicado: (2022)

Fluvoxamine for the treatment of COVID-19
por: Kim, Hyun, et al.
Publicado: (2022)

Fluvoxamine for the treatment of COVID-19
por: Marzolini, Catia, et al.
Publicado: (2022)

The role of carbon monoxide and heme oxygenase-1 in COVID-19
por: Kwong, Kenneth K., et al.
Publicado: (2020)

Heme oxygenase-1 as an important predictor of the severity of COVID-19
por: Hara, Yu, et al.
Publicado: (2022)

Heme Oxygenase-1 Deficiency
por: Renji, Soumya, et al.
Publicado: (2021)

Targeting the Heme-Heme Oxygenase System to Prevent Severe Complications Following COVID-19 Infections
por: Wagener, Frank A. D. T. G., et al.
Publicado: (2020)

Heme oxygenase-1: emerging target of cancer therapy
por: Chau, Lee-Young
Publicado: (2015)

Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?
por: Marcec, Robert, et al.
Publicado: (2022)

Fluvoxamine Plays an Integral Role in the Alteration of Sexual Behavioral Pattern more in Females than Males
por: Santra, Ranjita
Publicado: (2012)

Delirium, sleep, COVID-19 and melatonin
por: Wiwanitkit, Viroj
Publicado: (2020)

Ramelteon, as a Melatonin Agonist, is Expected to be Effective on COVID-19 Induced Organ Damage: The Hypothetic Role of NF-κB Signaling Pathway
por: Mehdipoor, Mahdis, et al.
Publicado: (2022)

Role of Heme Oxygenase as a Modulator of Heme-Mediated Pathways
por: Duvigneau, J. Catharina, et al.
Publicado: (2019)

Heme-heme oxygenase-2 reduces the atherosclerosis by preventing inflammation
por: Wang, Zhenzhen, et al.
Publicado: (2022)

Comment on: “Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence”
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)

Fluvoxamine for symptomatic outpatients with COVID-19
por: Wu, Peter E., et al.
Publicado: (2022)

A noncanonical heme oxygenase specific for the degradation of c-type heme
por: Li, Shuxin, et al.
Publicado: (2021)

Peroxynitrite-mediated inactivation of heme oxygenases
por: Kinobe, Robert, et al.
Publicado: (2004)

Heme oxygenase 1 regulates osteoclastogenesis
por: Zwerina, J, et al.
Publicado: (2005)

Curcumin and Heme Oxygenase: Neuroprotection and Beyond
por: Mhillaj, Emanuela, et al.
Publicado: (2019)

The non-canonical functions of the heme oxygenases
por: Vanella, Luca, et al.
Publicado: (2016)

Fluvoxamine
por: DeVane, C Lindsay
Publicado: (2005)

Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?
por: Corona, Daniela, et al.
Publicado: (2020)

Therapeutic Efficacy of Stem Cells Transplantation in Diabetes: Role of Heme Oxygenase
por: Raffaele, Marco, et al.
Publicado: (2016)

Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists
por: Khani, Elnaz, et al.
Publicado: (2022)

Desaturation and heme elevation during COVID-19 infection: A potential prognostic factor of heme oxygenase-1
por: Su, Wen-Lin, et al.
Publicado: (2021)

Integrative Survival Response Evoked by Heme Oxygenase-1 and Heme Metabolites
por: Pae, Hyun-Ock, et al.
Publicado: (2008)

How Heme Oxygenase-1 Prevents Heme-Induced Cell Death
por: Lanceta, Lilibeth, et al.
Publicado: (2015)

Heme, Heme Oxygenase-1, Statins, and SARS-CoV-2
por: Stevenson, David K., et al.
Publicado: (2023)

Therapeutic Roles of Heme Oxygenase-1 in Metabolic Diseases: Curcumin and Resveratrol Analogues as Possible Inducers of Heme Oxygenase-1
por: Son, Yong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kgcgppcdvuuoe0pv6jp6qbs155